Mrittika Bhaumik
About Mrittika Bhaumik
Mrittika Bhaumik is a Senior Manager of CMC Strategy at Instil Bio, where she has worked since 2021. She has extensive experience in process development and engineering, having held positions at Allogene Therapeutics, Kite Pharma, Genentech, and Bristol-Myers Squibb.
Current Role at Instil Bio
Mrittika Bhaumik serves as the Senior Manager of CMC Strategy at Instil Bio, a position she has held since 2021. In this role, she collaborates closely with Technical Development, Quality, and Manufacturing teams to establish phase-appropriate CMC strategies for TIL therapy development. Additionally, she leads a cross-functional team responsible for authoring sections within CMC module 3 for regulatory submissions.
Previous Experience at Allogene Therapeutics
Prior to her current role, Mrittika Bhaumik worked at Allogene Therapeutics as a Scientist in Process and Product Development from 2019 to 2021. During her tenure, she contributed to the development of innovative therapies in the biotechnology sector while based in the San Francisco Bay Area.
Experience at Kite Pharma
Mrittika Bhaumik held multiple positions at Kite Pharma. She served as a Process Engineer III in Process Development from 2017 to 2019, and briefly as a Senior Engineer I in Process Development in 2019. Her work in the Greater Los Angeles Area focused on advancing the company’s process development initiatives.
Educational Background
Mrittika Bhaumik earned a Bachelor of Science degree with a double major in Chemical and Biomedical Engineering from Carnegie Mellon University. This educational foundation has equipped her with the technical knowledge and skills necessary for her roles in the biotechnology and pharmaceutical industries.
Early Career Experience
Mrittika Bhaumik began her career with an internship at Bayer Pharmaceuticals in 2011, where she gained initial exposure to the pharmaceutical industry. She later worked at Bristol-Myers Squibb as an Associate Engineer in Manufacturing Support from 2012 to 2013, and at Genentech as an Engineer I in Purification Development from 2013 to 2017, further developing her expertise in process engineering.